Related Experiment Videos
Idiotypic control of the immune response
R Valderrama1, A E Eggers, S Revan
1Department of Neurology, SUNY Health Science Center, Brooklyn 11203.
Journal of Neuroimmunology
|December 1, 1988
Summary
Anti-idiotypic antibodies target specific regions of antibodies, acting as internal images of antigens. In experimental myasthenia gravis, these antibodies offer protection and influence disease-related binding.
Area of Science:
- Immunology
- Biochemistry
Background:
- Anti-idiotypic antibodies are defined by their binding to the unique antigenic determinants (idiotypes) of other antibodies.
- These antibodies (Ab2 alpha, Ab2 beta, Ab2 gamma) interact with the antigen-binding site or mimic antigen properties.
- Idiotypes and anti-idiotypes are integral components of both T-cell and B-cell immune systems.
Purpose of the Study:
- To explore the diverse applications of anti-idiotypic antibodies in biological research and therapeutic interventions.
- To investigate the specific roles and effects of anti-idiotypes in the context of experimental myasthenia gravis.
Main Methods:
- Characterization of anti-idiotypic antibody binding sites (alpha, beta, gamma).
- Analysis of idiotype-anti-idiotype interactions within T- and B-cell systems.
- Assessment of anti-idiotype efficacy in a model of experimental myasthenia gravis.
Main Results:
- Anti-idiotypes have been utilized for receptor and ligand purification and characterization.
- Applications include tumor treatment, vaccine development, and immune response modulation.
- In experimental myasthenia gravis, anti-idiotypes demonstrated protective effects, inhibited idiotype binding, and shared specificities.
Conclusions:
- Anti-idiotypic antibodies represent a versatile tool with broad applications in immunology and medicine.
- Their demonstrated efficacy in experimental myasthenia gravis suggests potential therapeutic value for autoimmune diseases.